Janney Capital Management’s ARK Genomic Revolution ETF ARKG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-159,962
Closed -$14.9M 201
2020
Q4
$14.9M Sell
159,962
-4,973
-3% -$396K 1.03% 25
2020
Q3
$10.5M Buy
+164,935
New +$9.66M 0.72% 55

Other funds holding ARKG

Janney Capital Management's ARKG Position: Q1 2021 in Review

Janney Capital Management sold out of ARK Genomic Revolution ETF (ARKG) in Q1 2021, closing a stake of 159,962 shares — an estimated $14.9M sold.

Janney Capital Management first reported a position in ARKG in Q3 2020 and held it in 2 quarters. The position peaked at $14.9M in Q4 2020. 505 funds tracked by Wall St. Rank hold ARKG as of Q1 2021.

  • Janney Capital Management reported no remaining ARK Genomic Revolution ETF position as of Q1 2021 after selling out during the quarter.
  • Janney Capital Management sold 159,962 ARK Genomic Revolution ETF shares in Q1 2021, an estimated $14.9M.
  • Janney Capital Management first reported a position in ARK Genomic Revolution ETF in Q3 2020 and held it in 2 quarters.
  • Janney Capital Management's ARK Genomic Revolution ETF position peaked at $14.9M in Q4 2020.
  • 505 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q1 2021.

Based on Janney Capital Management's 13F filing for Q1 2021, filed 27 Apr 2021.